Tokyo, Japan

Takashi Kamikubo

USPTO Granted Patents = 31 


 

Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 200(Granted Patents)


Location History:

  • Kawasaki, JP (2001 - 2002)
  • Ibaraki, JP (2003 - 2004)
  • Chuo-ku, JP (2009)
  • Kanagawa, JP (2009 - 2010)
  • Numazu, JP (2013)
  • Yokohama, JP (2016)
  • Minato, JP (2020)
  • Tokyo, JP (1997 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):

Title: Takashi Kamikubo: A Pioneer in Pharmaceutical Innovations

Introduction

Takashi Kamikubo, based in Tokyo, Japan, is an accomplished inventor with an impressive portfolio of 30 patents. His work in the pharmaceutical field is making significant contributions to the treatment of various diseases, particularly cancer and neuromuscular disorders.

Latest Patents

Among his latest inventions are two noteworthy patents. The first introduces a heteroaryl carboxamide compound, which serves as an active ingredient for pharmaceutical compositions aimed at treating cancer linked to immune cell activation or those resistant to anti-PD-1 antibody/anti-PD-L1 antibody therapies. This innovation demonstrates a DGK ξ (DGKzeta) inhibitory effect, showcasing its potential as a therapeutic agent for cancer treatment.

The second patent focuses on novel tetrahydroisoquinoline derivative compounds. These compounds can be utilized as active ingredients in pharmaceutical compositions for a variety of conditions, including neuromuscular disorders and musculoskeletal dysfunctions. By modulating the contractility of skeletal muscles, particularly through the troponin complex, these derivatives hold promise for treating a range of diseases characterized by muscle weakness and dysfunction.

Career Highlights

Throughout his career, Takashi Kamikubo has worked with prominent companies in the pharmaceutical industry, notably Nuflare Technology, Inc. and Astellas Pharma GmbH. His contributions have led to significant advancements in drug development and therapeutic strategies.

Collaborations

Kamikubo has collaborated with notable professionals in his field, including Hirohito Anze and Ippei Sato. These partnerships have facilitated the exchange of ideas and expertise, enhancing the effectiveness of his research and resulting in innovative pharmaceutical solutions.

Conclusion

Takashi Kamikubo's inventive spirit and dedication to advancing pharmaceutical technology have made him a key player in the innovation landscape. His research and patents continue to pave the way for breakthroughs in treatments for cancer and neuromuscular disorders, reflecting his commitment to improving patient outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…